Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif

References

• Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 1987; 237:888-93; PMID:3497453; http://dx.doi.org/10.1126/science.3497453
   PubMed Web of Science ®Google Scholar
• Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin MA. The HIV A (sor) gene product is essential for virus infectivity. Nature 1987; 328:728-30; PMID:2441266; http://dx.doi.org/10.1038/328728a0
   PubMed Web of Science ®Google Scholar
• Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418:646-50; PMID:12167863; http://dx.doi.org/10.1038/nature00939
   PubMed Web of Science ®Google Scholar
• Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003; 114:21-31; PMID:12859895; http://dx.doi.org/10.1016/S0092-8674(03)00515-4
   PubMed Web of Science ®Google Scholar
• Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003; 302:1056-60; PMID:14564014; http://dx.doi.org/10.1126/science.1089591
   PubMed Web of Science ®Google Scholar
• Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003; 9:1398-403; PMID:14528301; http://dx.doi.org/10.1038/nm946
   PubMed Web of Science ®Google Scholar
• Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003; 9:1404-7; PMID:14528300; http://dx.doi.org/10.1038/nm945
   PubMed Web of Science ®Google Scholar
• Liu B, Yu X, Luo K, Yu Y, Yu XF. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol 2004; 78:2072-81; PMID:14747572; http://dx.doi.org/10.1128/JVI.78.4.2072-2081.2004
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem 2005; 280:18573-8; PMID:15781449; http://dx.doi.org/10.1074/jbc.C500082200
   PubMed Web of Science ®Google Scholar
• Simon V, Zennou V, Murray D, Huang Y, Ho DD, Bieniasz PD. Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. PLoS Pathogens 2005; 1:e6; PMID:16201018; http://dx.doi.org/10.1371/journal.ppat.0010006
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, et al. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. Virology 2006; 344:263-6; PMID:16303161; http://dx.doi.org/10.1016/j.virol.2005.10.028
   PubMed Web of Science ®Google Scholar
• Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 2004; 18:2867-72; PMID:15574593; http://dx.doi.org/10.1101/gad.1250204
   PubMed Web of Science ®Google Scholar
• Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev 2004; 18:2861-6; PMID:15574592; http://dx.doi.org/10.1101/gad.1249904
   PubMed Web of Science ®Google Scholar
• Sakai H, Shibata R, Sakuragi J, Sakuragi S, Kawamura M, Adachi A. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol 1993; 67:1663-6; PMID:8437236
   PubMed Web of Science ®Google Scholar
• Zhang W, Du J, Evans SL, Yu Y, Yu XF. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. Nature 2012; 481:376-9
   Web of Science ®Google Scholar
• Han X, Liang W, Hua D, Zhou X, Du J, Evans SL, Gao Q, Wang H, Viqueira R, Wei W, et al. Evolutionarily conserved requirement for core binding factor β in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase. J Virol 2014; 88:3320-8; PMID:24390335; http://dx.doi.org/10.1128/JVI.03833-13
   PubMed Web of Science ®Google Scholar
• Zhou X, Evans SL, Han X, Liu Y, Yu XF. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFbeta and CRL5 E3 ubiquitin ligase components. PloS One 2012; 7:e33495; PMID:22479405; http://dx.doi.org/10.1371/journal.pone.0033495
   PubMed Web of Science ®Google Scholar
• Zhou X, Han X, Zhao K, Du J, Evans SL, Wang H, Li P, Zheng W, Rui Y, Kang J, et al. Dispersed and Conserved Hydrophobic Residues of HIV-1 Vif Are Essential for CBFbeta Recruitment and A3G Suppression. J Virol 2014; 88:2555-63; PMID:24352440; http://dx.doi.org/10.1128/JVI.03604-13
   PubMed Web of Science ®Google Scholar
• Guo Y, Dong L, Qiu X, Wang Y, Zhang B, Liu H, Yu Y, Zang Y, Yang M, Huang Z. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif. Nature 2014; 505:229-33; PMID:24402281; http://dx.doi.org/10.1038/nature12884
   PubMed Web of Science ®Google Scholar
• Du J, Zhao K, Rui Y, Li P, Zhou X, Zhang W, Yu XF. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor β. J Virol 2013; 87:1906-11; PMID:23175372; http://dx.doi.org/10.1128/JVI.02199-12
   PubMed Web of Science ®Google Scholar
• Hultquist JF, McDougle RM, Anderson BD, Harris RS. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces. AIDS Res Hum Retroviruses 2012; 28:1543-51; PMID:22725134; http://dx.doi.org/10.1089/aid.2012.0142
   PubMed Web of Science ®Google Scholar
• Wang H, Liu B, Liu X, Li Z, Yu X-F, Zhang W. Identification of HIV-1 Vif Regions Required for CBF-β Interaction and APOBEC3 Suppression. PloS One 2014; 9:e95738; PMID:24810617; http://dx.doi.org/10.1371/journal.pone.0095738
   PubMed Web of Science ®Google Scholar
• Luo K, Xiao Z, Ehrlich E, Yu Y, Liu B, Zheng S, Yu XF. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A 2005; 102:11444-9; PMID:16076960; http://dx.doi.org/10.1073/pnas.0502440102
   PubMed Web of Science ®Google Scholar
• Xiao Z, Ehrlich E, Yu Y, Luo K, Wang T, Tian C, Yu XF. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 2006; 349:290-9; PMID:16530799; http://dx.doi.org/10.1016/j.virol.2006.02.002
   PubMed Web of Science ®Google Scholar
• Mehle A, Thomas ER, Rajendran KS, Gabuzda D. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem 2006; 281:17259-65; PMID:16636053; http://dx.doi.org/10.1074/jbc.M602413200
   PubMed Web of Science ®Google Scholar
• Paul I, Cui J, Maynard EL. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions. Proc Natl Acad Sci U S A 2006; 103:18475-80; PMID:17132731; http://dx.doi.org/10.1073/pnas.0604150103
   PubMed Web of Science ®Google Scholar
• Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J 2007; 21:217-22; PMID:17135358; http://dx.doi.org/10.1096/fj.06-6773com
   PubMed Web of Science ®Google Scholar
• Xiao Z, Xiong Y, Zhang W, Tan L, Ehrlich E, Guo D, Yu XF. Characterization of a novel Cullin5 binding domain in HIV-1 Vif. J Mol Biol 2007; 373:541-50; PMID:17869271; http://dx.doi.org/10.1016/j.jmb.2007.07.029
   PubMed Web of Science ®Google Scholar
• Evans SL, Schon A, Gao Q, Han X, Zhou X, Freire E, Yu XF. HIV-1 Vif N-terminal Motif is required for recruitment of Cul5 to Suppress APOBEC3. Retrovirology 2014; 11:4; PMID:24422669; http://dx.doi.org/10.1186/1742-4690-11-4
   PubMed Web of Science ®Google Scholar
• Giri K, Maynard EL. Conformational analysis of a peptide approximating the HCCH motif in HIV-1 Vif. Biopolymers 2009; 92:417-25; PMID:19382167; http://dx.doi.org/10.1002/bip.21209
   PubMed Web of Science ®Google Scholar
• Giri K, Scott RA, Maynard EL. Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif. Biochemistry 2009; 48:7969-78; PMID:19588889; http://dx.doi.org/10.1021/bi900677w
   PubMed Web of Science ®Google Scholar
• He Z, Zhang W, Chen G, Xu R, Yu XF. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 2008; 381:1000-11; PMID:18619467; http://dx.doi.org/10.1016/j.jmb.2008.06.061
   PubMed Web of Science ®Google Scholar
• Pery E, Rajendran KS, Brazier AJ, Gabuzda D. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J Virol 2009; 83:2374-81; PMID:19109396; http://dx.doi.org/10.1128/JVI.01898-08
   PubMed Web of Science ®Google Scholar
• Chen G, He Z, Wang T, Xu R, Yu XF. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J Virol 2009; 83:8674-82; PMID:19535450; http://dx.doi.org/10.1128/JVI.00653-09
   PubMed Web of Science ®Google Scholar
• Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J Virol 2006; 80:3112-5; PMID:16501124; http://dx.doi.org/10.1128/JVI.80.6.3112-3115.2006
   PubMed Web of Science ®Google Scholar
• Russell RA, Pathak VK. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol 2007; 81:8201-10; PMID:17522216; http://dx.doi.org/10.1128/JVI.00395-07
   PubMed Web of Science ®Google Scholar
• OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008; 4:249-59; PMID:18779051; http://dx.doi.org/10.1016/j.chom.2008.07.005
   PubMed Web of Science ®Google Scholar
• Harari A, Ooms M, Mulder LC, Simon V. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H. J virol 2009; 83:295-303; PMID:18945781; http://dx.doi.org/10.1128/JVI.01665-08
   PubMed Web of Science ®Google Scholar
• Tan L, Sarkis PT, Wang T, Tian C, Yu XF. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB J 2009; 23:279-87; PMID:18827027; http://dx.doi.org/10.1096/fj.07-088781
   PubMed Web of Science ®Google Scholar
• Ooms M, Brayton B, Letko M, Maio SM, Pilcher CD, Hecht FM, Barbour JD, Simon V. HIV-1 Vif adaptation to human APOBEC3H haplotypes. Cell Host Microbe 2013; 14:411-21; PMID:24139399; http://dx.doi.org/10.1016/j.chom.2013.09.006
   PubMed Web of Science ®Google Scholar
• Binka M, Ooms M, Steward M, Simon V. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. J Virol 2012; 86:49-59; PMID:22013041; http://dx.doi.org/10.1128/JVI.06082-11
   PubMed Web of Science ®Google Scholar
• Ooms M, Letko M, Binka M, Simon V. The resistance of human APOBEC3H to HIV-1 NL4-3 molcular clone is determined by a single amino acid in Vif. PloS One 2013; 8:e57744; PMID:23469063; http://dx.doi.org/10.1371/journal.pone.0057744
   PubMed Web of Science ®Google Scholar
• Sakai K, Dimas J, Lenardo MJ. The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest. Proc Natl Acad Sci 2006; 103:3369-74; http://dx.doi.org/10.1073/pnas.0509417103
   PubMed Web of Science ®Google Scholar
• Wang J, Shackelford JM, Casella CR, Shivers DK, Rapaport EL, Liu B, Yu XF, Finkel TH. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells. Virology 2007; 359:243-52; PMID:17056089; http://dx.doi.org/10.1016/j.virol.2006.09.026
   PubMed Web of Science ®Google Scholar
• Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, et al. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci U S A 2010; 107:20798-803; PMID:21071676; http://dx.doi.org/10.1073/pnas.1008076107
   PubMed Web of Science ®Google Scholar
• Zhen A, Wang T, Zhao K, Xiong Y, Yu XF. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J Virol 2010; 84:1902-11; PMID:19939923; http://dx.doi.org/10.1128/JVI.01509-09
   PubMed Web of Science ®Google Scholar
• Zhen A, Du J, Zhou X, Xiong Y, Yu XF. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities. PloS One 2012; 7:e38771; PMID:22859935; http://dx.doi.org/10.1371/journal.pone.0038771
   PubMed Web of Science ®Google Scholar
• Wang J, Reuschel EL, Shackelford JM, Jeang L, Shivers DK, Diehl JA, Yu XF, Finkel TH. HIV-1 Vif promotes the G(1)- to S-phase cell-cycle transition. Blood 2011; 117:1260-9; PMID:21149631; http://dx.doi.org/10.1182/blood-2010-06-289215
   PubMed Web of Science ®Google Scholar
• Wang J, Shackelford JM, Selliah N, Shivers DK, O'Neill E, Garcia JV, Muthumani K, Weiner D, Yu X-F, Gabuzda D, et al. The HIV-1 Vif Protein Mediates Degradation of Vpr and Reduces Vpr-Induced Cell Cycle Arrest. DNA Cell Biol 2008; 27:267-77; PMID:18462066; http://dx.doi.org/10.1089/dna.2007.0707
   PubMed Web of Science ®Google Scholar
• Jager S, Kim DY, Hultquist JF, Shindo K, Larue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, et al. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature 2012; 481:371-5; PMID:22190037; http://dx.doi.org/10.1038/nature10693
   PubMed Web of Science ®Google Scholar
• Hultquist JF, Binka M, Larue RS, Simon V, Harris RS. Vif proteins of human and simian immunodeficiency viruses require cellular CBFbeta to degrade APOBEC3 restriction factors. J Virol 2012; 86:2874-7; PMID:22205746; http://dx.doi.org/10.1128/JVI.06950-11
   PubMed Web of Science ®Google Scholar